-

Scylla, Charybdis and emerging market equities

Through the narrow path

In Greek myth, Scylla and Charybdis were two immortal and irresistible monsters who preyed on sailors in the narrow straits of Messina. Plotting the path between this vengeful pair proved too difficult for many. Even Odysseus barely survived the ordeal.

Investors in emerging market equities are currently being subjected to a similar examination at the hands of higher US interest rates on one side and rising protectionism on the other.

We continue to lean portfolios towards emerging market equities, in particular Asia, in the expectation that these trials will be passed. We explore why in more detail below.

The devil...

It is still difficult to discern the impact of escalating trade tensions in the economic data. Front-loading of orders and shipments ahead of the imposition of tariffs will likely distort our view for a while yet too.

Nonetheless, emerging market assets, particularly in Asia, have underperformed the rest of the world seemingly in anticipation of these negative economic effects.

We need to be wary of overconfidence here. We cannot pretend to know for sure that the escalation seen in the last month is part of a crude negotiating strategy on the part of the US administration.

However, as November’s US midterm elections loom larger, we see economic and political self-interest helping to de-escalate the scrap. In the meantime, the potential for capital markets to be dragged into a disciplinary role suggests investors will again need to call upon their stores of composure to see this through.

...and the deep blue sea

Absent the aforementioned tensions, the currently healthy global economic backdrop is traditionally one that sees emerging market equities outperform more often than not (Figure 1).

EM tends to outperform during non recessionary periods

US consumption is booming, investment is finally picking up more forcefully around the world, and global trade volumes are following suit.

As a result, corporate profitability in the region and forward earnings expectations have been rowing against the tide of falling prices. However, it is not only trading tensions that have been unnerving emerging market investors, but also a perhaps overly-rigid reading of the historical playbook.

The past would teach us that higher US interest rates and a rising dollar are the times to be wary of emerging markets. Businesses that have borrowed heavily in dollars can find increasing mismatches between domestically oriented revenues and dollar interest rates. So go the economies in question too. However, as we have pointed out before, the degree of mismatch (and mismanagement) this time around looks to be more isolated1 (Figure 2).

EM economies have gradually reduced their trade deficits

Argentina, South Africa and Turkey look vulnerable to higher US interest rates, but the emerging market space in aggregate looks more able to digest them given lower dollar exposures and better-balanced domestic economies.

Investment conclusion:  wait out the hiatus

Some hiatus following last year’s phenomenal ascent in emerging market equities was inevitable. The fundamental inputs for further outperformance over the next 6 – 12 months remain present and correct in our opinion, though patience and composure are likely to still be required.

This document is from the Investments division at Barclays Private Bank & Overseas Services (“PBOS”) division and is not a product of the Barclays Research department. Any views expressed may differ from those of Barclays Research. All opinions and estimates are given as of the date hereof and are subject to change.

No representation is made as to the accuracy of the assumptions made within, or completeness of, any modelling, scenario analysis or back-testing. Barclays is not responsible for information stated to be obtained or derived from third party sources or statistical services. Barclays is not offering to sell or seeking offers to buy any product or enter into any transaction.

Any offer or entry into any transaction requires Barclays’ subsequent formal agreement which will be subject to internal approvals and execution of binding transaction documents. Any past or simulated past performance including back-testing, modelling or scenario analysis contained herein is no indication as to future performance.

Neither Barclays nor any of its directors, officers, employees, representatives or agents, accepts any liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this communication or its contents or reliance on the information contained herein, except to the extent this would be prohibited by law or regulation.

The value of any investment may also fluctuate as a result of market changes. Barclays is not obliged to inform the recipients of this communication of any change to such opinions or estimates. THIS COMMUNICATION IS PROVIDED FOR INFORMATION PURPOSES ONLY AND IT IS SUBJECT TO CHANGE. IT IS INDICATIVE ONLY AND IS NOT BINDING.

This document is not directed to, nor intended for distribution or use by, any person or entity in any jurisdiction or country where the publication or availability of this document or such distribution or use would be contrary to local law or regulation. It may not be reproduced or disclosed (in whole or in part) to any other person without prior written permission. You should not take notice of this document if you know that your access would contravene applicable local, national or international laws. The contents of this publication have not been reviewed or approved by any regulatory authority.

This document was drafted by and the views presented are those of Barclays Bank (Suisse) SA as of the date of the brochure and may be subject to change in the future. The information contained in this document is intended for general circulation only. This document shall not constitute advice or an offer by Barclays Bank (Suisse) SA to subscribe to any service or product or enter into any transaction.

All legal terms and conditions are to be found in the general account terms and conditions of Barclays Bank (Suisse) SA together with the legal terms and conditions of the product or service offered. Barclays Bank (Suisse) SA has made every effort to ensure that the information contained in this document is reliable, exhaustive and accurate.

This document is general in nature and does not take into account the specific investment objectives, financial situation, knowledge, experience or particular needs of any particular person. The products and services presented in this publication may not be appropriate or suitable for all investors. Advice should be sought from a financial adviser regarding the appropriateness and suitability of the investment products and services mentioned herein, taking into account your specific objectives, financial situation, knowledge, experience and particular needs before you make any commitment to purchase any such investment services or related products.

Neither Barclays Bank (Suisse) SA nor any of their respective officers, partners or employees accepts any liability whatsoever for any direct or consequential loss arising for any use of or reliance upon this publication or its contents, or for any omission.